Live feed08:00:00·555dPRReleasevia QuantisnowMedera Announces Completion of Cohort A and Initiation of Dosing in Cohort B of MUSIC-HFpEF, a Phase 1/2a Clinical Trial Evaluating First-In-Human Gene Therapy SRD-002 for Heart Failure with Preserved Ejection FractionByQuantisnow·Wall Street's wire, on your screen.KVAC· Keen Vision Acquisition Corporation
